rss
J Med Genet 2009;46:136-144 doi:10.1136/jmg.2008.062570
  • Mutation report

Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy

  1. N Fuhrmann1,
  2. M V Alavi1,
  3. P Bitoun2,
  4. S Woernle3,
  5. G Auburger4,
  6. B Leo-Kottler5,
  7. P Yu-Wai-Man6,7,
  8. P Chinnery6,
  9. B Wissinger1
  1. 1
    Molecular Genetics Laboratory, Institute for Ophthalmic Research, Centre for Ophthalmology, University Clinics Tuebingen, Germany
  2. 2
    Genetique Medicale Hôpital Jean Verdier, CHU Paris Nord, Bondy Cedex, France
  3. 3
    Department of Pediatrics, Clinical Centre of Traunstein, Traunstein, Germany
  4. 4
    Section Molecular Neurogenetics, Department of Neurology, University Clinics Frankfurt, Germany
  5. 5
    University Eye Hospital, Centre for Ophthalmology, University Clinics Tuebingen, Germany
  6. 6
    Mitochondrial Research Group, The Medical School, Newcastle University, UK
  7. 7
    Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
  1. Dr B Wissinger, Molecular Genetics Laboratory, Centre for Ophthalmology, Röntgenweg 11, D-72076 Tübingen, Germany; wissinger{at}uni-tuebingen.de
  • Received 11 August 2008
  • Revised 10 October 2008
  • Accepted 16 October 2008

Abstract

Introduction: Autosomal dominant optic atrophy (ADOA) is considered as the most common form of hereditary optic neuropathy. Although genetic linkage studies point to the OPA1 locus on chromosome 3q28–q29 as by far the most common gene locus, previous screening studies—based on sequencing of the coding exons—detected OPA1 mutations in only 32–70% of ADOA patients. We therefore hypothesised that larger deletions or duplications that remained undetected in previous screening approaches may substantially contribute to the prevalence of OPA1 mutations in ADOA.

Methods: 42 independent ADOA patients were analysed for the presence of genomic rearrangements in OPA1 by means of multiplex ligation probe amplification (MLPA). Deletions or duplications were confirmed either by long distance polymerase chain reaction (PCR) and breakpoint sequencing or loss of heterozygosity analyses with flanking microsatellite markers. Patients underwent ophthalmological examination including visual acuity, colour vision testings, perimetry and funduscopy.

Results: We identified genomic rearrangements in 8 of 42 patients, including single exon deletions of exon 9 and exon 24, respectively, a deletion of exons 1–5, two different deletions of the complete OPA1 gene as well as a duplication of the exons 7–9, with the latter being present in three unrelated families. Patients’ phenotypes were highly variable, similar to patients with point mutation in OPA1.

Discussion: Our findings show that gross genomic aberrations at the OPA1 gene locus are frequent in ADOA and substantially contribute to the spectrum and prevalence of OPA1 mutations in ADOA patients. They further strengthen the hypothesis that haploinsufficiency is a major pathomechanism in OPA1 associated ADOA.

Footnotes

  • Competing interests: None.

This Article

Services

  1. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JMG.
View free sample issue >>

Free archive
The full back archive is now available for JMG. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest genetics jobs

    Latest genetics jobs